Future Therapeutic Trends in Osteoarthritis

References

• Friedman M J, Berasi C C, Fox J M, et al. Preliminary results with abrasion arthroplasty in osteoarthritic htee. Clin Orthop Res 1984; 182: 200–5
   Google Scholar
• Kleiner J B, Coutts R D, Woo SL-Y, et al. The short term evaluation of different treatment modalities upon fullthickness articular cartilage defects: A study of rib perichondria! chondrogenesis. Trans Orthop Res Soc 1986; 11: 282
   Google Scholar
• Zarnett R, Salter RB. The cellular origin and evolution of hyaline-like cartilage produced by free periosteal grafts under the influence of continuous passive motion. Trans Orthop Res Soc 1986; 11: 279
   Google Scholar
• Czitrom A A, Langer F, McKee N, Gross AE. Bane and cartilage allotransplantation. Clin Orthop 1986; 208: 141–5
   PubMed Web of Science ®Google Scholar
• Garrett JC. Treatment of osteochondral defects of the distal femur with fresh osteochondral allografts: A preliminary report. Arthroscopy 1986; 2: 222–6
   PubMedGoogle Scholar
• Salter R B, Simmonds D F, Malcolm B W, Rumble E J, MacMichael D, Clements ND. The biological effect of continuous passive motion on the healing of full-thickness defects in articular cartilage: An experimental investigation in the rabbit. J Bone Joint Surg 1980; 62A: 1232–50
   Google Scholar
• O'Driscoll S W, Keeley F W, Salter RB. The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. J Bone Joint Surg 1986; 68-A: 1017–35
   Google Scholar
• Davidson J M, Klagsbrun M, Hill K E, et al. Accelerated wound repair, cell proliferation and collagen accumulation are produced by cartilage derived growth factor. J Cell Biol 1985; 100: 1219–27
   PubMed Web of Science ®Google Scholar
• Sporn M B, Roberts A B, Wakefield L M, et al. Transforming growth factor-B: Biological function and chemical structure. Science 1986; 233: 532–4
   PubMed Web of Science ®Google Scholar
• Castor C W, Fremuth T O, Roberts D J, et al. Regulation of articular cell metabolism by CTAP mediators. Semin Arthritis Rheum 1981; 1: 95–6, Suppl 1
   Google Scholar
• Zezulak K M, Green H. The generation of insulin-like growth factor-1-sensitive cells by growth hormone action. Science 1986; 233: 551–3
   PubMed Web of Science ®Google Scholar
• Daughaday W H, Hall K, Raben M S, et al. Somatomedin: Proposed designation for sulpliation factor. Nature 1975; 235: 107
   Google Scholar
• Howell DS. Pathogenesis of OA. Am J Med 1986; 80: 24–8, Suppl 4B
   PubMed Web of Science ®Google Scholar
• Colombo C, Butler M, Hickman M, et al. A new model of osteoarthritis in rabbits: II. Evaluation of antiostcoarthritic effects of selected antirheumatic drugs administered systemically. Arthritis Rheum 1983; 26: 1132–9
   PubMed Web of Science ®Google Scholar
• Pelletier J P, Martel-Pelletier J, Malemud CI. Canine osteoarthritis: Effects of endogenous neutral metalloproteogfycanases on articular cartilage proteoglycans. J Orthop Res 1988; 6: 379–88
   PubMed Web of Science ®Google Scholar
• Steinberg J, Tsukamoto S, Sledge CB. A tissue culture model of cartilage breakdown in rheumatoid arthritis: II. Effects of antirheumatic drugs. Arthritis Rheum 1979; 22: 877–85
   Google Scholar
• Kalbhen D A, Felten K. Effects of tribenoside (GfyvenolR) on experimental osteoarthrosis. Pharmacology 1979; 19: 68–74
   Google Scholar
• Butler K, Lewis GP. The effect of anti-inflammatory compounds on the biochemical changes in the Arthus reaction. J Pathol 1976; 119: 175–82
   Google Scholar
• Trnavsky K. Some effects of antiinflammatory drugs on connective tissue metabolism. Antiinflammatory Agents, Chemistry and Pharmacology. Medicinal Chemistry, R A Scherrer, M W White-House. Academic Press, New York 1974; Vol 13–11.: 304–26, A Series of Monographs
   Google Scholar
• Burkhardt D, Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum 1987; 17: 3–34, Suppl l
   PubMedGoogle Scholar
• Altman R D, Howell D S, Muniz O E, et al. The effect of glycosaminoglycan polysulfitric acid ester on articular cartilage in experimental artliritis. J Rheumatol 1987; 14: 127–9, Suppl
   PubMedGoogle Scholar
• Golding J, Ghosh P. Drugs for osteoarthrosis II. The effects of glycosaminoglycan polysulphate ester (Arteparon) on proteoglycan aggregation and loss from articular cartilage of immobilized rabbit knee joints. Curr Thera p Res 1983; 34: 67–80
   Web of Science ®Google Scholar
• Carreno M R, Muniz O E, Howell DS. The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis: Effects on morphological variables of disease severity. J Rheum 1986; 13: 490–7
   PubMedGoogle Scholar
• Howell D S, Muniz O E, Carreno MR. Effect of glycosaminoglycan polysulfate ester on proteoglycan-degrading enzyme activity in an animal model of OA. Adv Inflam Res 1986; 11: 197–206
   Google Scholar
• Howell D S, Carreno M R, Pelletier J-P, et al. Articular cartilage breakdown in a lapine model of osteoarthritis. Clin Orthop 1986; 213: 69–76
   Google Scholar
• Ehrlich M G, Armstrong A L, Mankin HI. Partial purification and characterization of a proteoglycan-degrading neutral protease from bovine epiphyseal cartilage. J Orthop Res 1984; 2: 126–33
   Google Scholar
• Ehrlich M G, Armstrong A L, Neuman R G, et al. Patterns of proteoglycan degradation by a neutral protease from human growth-plate epiphyseal cartilage. J Bone Joint Surg 1982; 64A: 1350–4
   Google Scholar
• Ehrlich M G, Houle P A, Vigliani G, et al. Correlation between articular cartilage collagenase activity and osteoarthritis. Arthritis Rheum 1978; 21: 761–6
   Google Scholar
• Kalbhen DA. The inhibitory effects of steroidal and nonsteroidal anti-rheumatic drugs on articular cartilage in osteoarthrosis and its counteraction by a biological GAG-peptide complex (Rumalon). Z Rheumatol 1982; 41: 202–11
   Google Scholar
• Newton C D, Fetter A, Bashey RI. Clinical studies and pathological changes in articular cartilage in experimental canine OA and effects of the in vivo administration of GAG-peptide complex from bone marrow and cartilage. Aktuel Rheumatol 1984; 9: 128–33
   Web of Science ®Google Scholar
• Malemud C J, Sokoloff L. Failure of Rumalon to increase sulfate incorporation by articular chondrocytes in monolayer culture. Arthritis Rheum 1971; 14: 779–80
   PubMed Web of Science ®Google Scholar
• Rejholec V. Long-term studies of antiosteoarthritic drugs: An assessment. Semin Arthritis Rheum 1987; 17: 35–53, Suppl 1
   PubMedGoogle Scholar